Julie M. Vose, MD, MBA, FASCO, Elected ASCO President for 2015–2016 Term


Get Permission

Julie M. Vose, MD, MBA, FASCO

Julie M. Vose, MD, MBA, FASCO, has been elected President of ASCO for a 1-year term beginning in June 2015. She will take office as President-Elect during the ASCO Annual Meeting in Chicago in June 2014.

“ASCO is a very diverse and multifaceted organization with so much to offer its membership. The recent enhancements in the educational offerings, quality improvement, broadened advocacy, and the potential for comparative effectiveness research with CancerLinQ™ are just a few of the ASCO areas where I believe my experience and training will add to the current activities,” Dr. Vose said. “I am excited to serve the ASCO membership as President and to make a difference for oncology professionals and our patients.”

Dr. Vose is the Neumann M. and Mildred E. Harris Professorial Chair and Chief of the Oncology/Hematology Division in the Department of Internal Medicine at the University of Nebraska Medical Center, and the Associate Director of Clinical Research and Co-Chair of the Lymphoma Program at the Fred and Pamela Buffet Cancer Center. Since joining ASCO in 1991, she has served on the Board of Directors, as Chair of the Cancer Education Committee, and is the current Chair-Elect of the Integrated Media and Technology Committee, among other activities.

Since 2006, Dr. Vose has served as the Associate Director of Clinical Research and is Co-Chair of the Lymphoma Program at the Fred and Pamela Buffet Cancer Center. She is a member of the Board of Directors for the University of Nebraska Medical Center Physicians Group. She is Co-Chair of the Lymphoma Steering Committee for the National Cancer Institute and serves on the U.S. Food and Drug Administration Oncologic Drugs Advisory Committee.

Additionally, four new members were elected to the ASCO Board of Directors and two new members to the ASCO Nominating Committee. See page 100 for information on these other newly elected members of ­ASCO’s Board of Directors and the ASCO Nominating Committee. ■



Advertisement

Advertisement



Advertisement